摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,3,5,5-tetramethyl-heptan-4-one | 20669-06-1

中文名称
——
中文别名
——
英文名称
3,3,5,5-tetramethyl-heptan-4-one
英文别名
α.α.α'.α'-Tetramethyl-α.α'-diaethyl-aceton;3,3,5,5-Tetramethyl-heptan-4-on;methyl-t-butyl ketone;methyl-tert-butyl ketone;3,3,5,5-Tetramethylheptan-4-one
3,3,5,5-tetramethyl-heptan-4-one化学式
CAS
20669-06-1
化学式
C11H22O
mdl
——
分子量
170.295
InChiKey
BJNASNZFXHMMCX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    195-200 °C
  • 密度:
    0.821±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    12
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.91
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] METAL ORGANIC COMPOUNDS<br/>[FR] COMPOSÉS ORGANOMÉTALLIQUES
    申请人:UMICORE AG & CO KG
    公开号:WO2021197597A1
    公开(公告)日:2021-10-07
    The invention concerns a process for preparing an essentially silicon (Si) free compounds of the general formula [M(O)(OR)y], wherein M = Mo, y = 3 or M = W, y = 3 or 4. Furthermore, it is directed towards compounds obtained by the aforementioned process and towards the use of such an obtained compound. Another objective of the herein described invention are essentially silicon free compounds of the general formula MOXy or [MOXy(solv)p], prepared using the aforementioned process, wherein M = Mo, y = 3 or M = W, y = 3 or 4, X = Cl or Br, solv = an oxidizing agent Z binding or coordinating to M via at least one donor atom, p = 1 or 2. The invention is also directed towards the use of essentially silicon free compounds prepared using the aforementioned process of the general formula MOXy or [MOXy(solv)p].
    该发明涉及一种制备通式[M(O)(OR)y]的基本无硅(Si)化合物的过程,其中M = Mo,y = 3或M = W,y = 3或4。此外,它针对通过上述过程获得的化合物以及利用这种获得的化合物的用途。所述发明的另一个目标是使用上述过程制备的通式MOXy或[MOXy(solv)p]的基本无硅化合物,其中M = Mo,y = 3或M = W,y = 3或4,X = Cl或Br,solv = 通过至少一个供体原子与M结合或配位的氧化剂Z,p = 1或2。该发明还涉及利用利用上述通式MOXy或[MOXy(solv)p]的基本无硅化合物的方法。
  • AMINOPYRIDINE COMPOUND
    申请人:Iwamura Ryo
    公开号:US20120259123A1
    公开(公告)日:2012-10-11
    The present invention relates to a compound represented by the formula (I): or a pharmaceutically acceptable salt thereof, a medical composition containing the same, and a medical composition for the treatment or prophylaxis of respiratory diseases or glaucoma.
    本发明涉及一种由以下公式(I)表示的化合物或其药学上可接受的盐,含有该化合物的医药组合物,以及用于治疗或预防呼吸道疾病或青光眼的医药组合物。
  • Aldol condensation reaction and catalyst therefore
    申请人:DSM IP Assets B.V.
    公开号:EP1997796A1
    公开(公告)日:2008-12-03
    The invention relates to a novel processes for cross aldol reactions using strongly basic, anionic, macroreticular polymeric resin with quaternary ammonium groups of the type -CH2N+(CH3)3 as heterogeneous catalysts. This catalyst is recyclable and the process can be repeated several times.
    该发明涉及一种新型的交叉Aldol反应过程,使用具有季铵基团的强碱性阴离子大孔树脂作为异质催化剂。该催化剂可循环使用,该过程可重复进行多次。
  • [EN] SALTS OF TIOTROPIUM WITH 10-CAMPHORSULFONIC ACID<br/>[FR] SELS DE TIOTROPIUM AVEC L'ACIDE 10-CAMPHRE SULFONIQUE
    申请人:ADAMED SP ZOO
    公开号:WO2010133457A1
    公开(公告)日:2010-11-25
    The present invention relates to novel tiotropium salts with 10-camphorsulphonic acid of formula (I), its optical isomers or their mixtures, their monohydrates, their anhydrous crystalline forms and processes for the preparation thereof, as well as to pharmaceutical compositions containing the same and to the use of novel salts for the treatment of respiratory tract diseases. (I)
    本发明涉及具有化学式(I)的新型环丙磺酸钛托溴铵盐,其光学异构体或它们的混合物,它们的一水合物,无水结晶形式以及其制备方法,以及含有这些盐的药物组合物,以及用于治疗呼吸道疾病的新型盐的用途。(I)
  • SALTS OF TIOTROPIUM WITH 10-CAMPHORSULFONIC ACID
    申请人:Modrzejewska Helena
    公开号:US20120065226A1
    公开(公告)日:2012-03-15
    The present invention relates to novel tiotropium salts with 10-camphorsulphonic acid of formula (I), its optical isomers or their mixtures, their monohydrates, their anhydrous crystalline forms and processes for the preparation thereof, as well as to pharmaceutical compositions containing the same and to the use of novel salts for the treatment of respiratory tract diseases.
    本发明涉及具有化学式(I)的新型环托必利盐,其光学异构体或它们的混合物,它们的单水合物,无水结晶形式以及其制备方法,以及含有这些盐的药物组合物,以及新型盐用于治疗呼吸道疾病的用途。
查看更多